Inflammatory Bowel Disease Relief Market, Global Outlook and Forecast 2022-2028

April 2022 | 68 pages | ID: ICAABC660F53EN
Market Monitor Global

Abstracts

Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative disease (UC), are proposed to result from an inappropriate immune response to the gut microbes in a genetically susceptible host.

This report contains market size and forecasts of Inflammatory Bowel Disease Relief in Global, including the following market information:

Global Inflammatory Bowel Disease Relief Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Inflammatory Bowel Disease Relief market was valued at 17780 million in 2021 and is projected to reach US$ 22520 million by 2028, at a CAGR of 3.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

TNF Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Inflammatory Bowel Disease Relief include Pfizer,Inc., Janssen Biotech,Inc.(Johnson&Johnson), Valeant Pharmaceuticals, Allerganplc., Takeda Pharmaceutical, AbbVie,Inc., Novartis AG, UCB Inc. and Biogen Inc.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inflammatory Bowel Disease Relief companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Inflammatory Bowel Disease Relief Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Inflammatory Bowel Disease Relief Market Segment Percentages, by Type, 2021 (%)

• TNF Inhibitors
• Aminosalicylates
• Integrin Antagonists
• Corticosteroids
• Others

Global Inflammatory Bowel Disease Relief Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Inflammatory Bowel Disease Relief Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Inflammatory Bowel Disease Relief Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Inflammatory Bowel Disease Relief Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Inflammatory Bowel Disease Relief revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Inflammatory Bowel Disease Relief revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer,Inc.
• Janssen Biotech,Inc.(Johnson&Johnson)
• Valeant Pharmaceuticals
• Allerganplc.
• Takeda Pharmaceutical
• AbbVie,Inc.
• Novartis AG
• UCB Inc.
• Biogen Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Inflammatory Bowel Disease Relief Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Inflammatory Bowel Disease Relief Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INFLAMMATORY BOWEL DISEASE RELIEF OVERALL MARKET SIZE

2.1 Global Inflammatory Bowel Disease Relief Market Size: 2021 VS 2028
2.2 Global Inflammatory Bowel Disease Relief Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Inflammatory Bowel Disease Relief Players in Global Market
3.2 Top Global Inflammatory Bowel Disease Relief Companies Ranked by Revenue
3.3 Global Inflammatory Bowel Disease Relief Revenue by Companies
3.4 Top 3 and Top 5 Inflammatory Bowel Disease Relief Companies in Global Market, by Revenue in 2021
3.5 Global Companies Inflammatory Bowel Disease Relief Product Type
3.6 Tier 1, Tier 2 and Tier 3 Inflammatory Bowel Disease Relief Players in Global Market
  3.6.1 List of Global Tier 1 Inflammatory Bowel Disease Relief Companies
  3.6.2 List of Global Tier 2 and Tier 3 Inflammatory Bowel Disease Relief Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Inflammatory Bowel Disease Relief Market Size Markets, 2021 & 2028
  4.1.2 TNF Inhibitors
  4.1.3 Aminosalicylates
  4.1.4 Integrin Antagonists
  4.1.5 Corticosteroids
  4.1.6 Others
4.2 By Type - Global Inflammatory Bowel Disease Relief Revenue & Forecasts
  4.2.1 By Type - Global Inflammatory Bowel Disease Relief Revenue, 2017-2022
  4.2.2 By Type - Global Inflammatory Bowel Disease Relief Revenue, 2023-2028
  4.2.3 By Type - Global Inflammatory Bowel Disease Relief Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Inflammatory Bowel Disease Relief Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Inflammatory Bowel Disease Relief Revenue & Forecasts
  5.2.1 By Application - Global Inflammatory Bowel Disease Relief Revenue, 2017-2022
  5.2.2 By Application - Global Inflammatory Bowel Disease Relief Revenue, 2023-2028
  5.2.3 By Application - Global Inflammatory Bowel Disease Relief Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Inflammatory Bowel Disease Relief Market Size, 2021 & 2028
6.2 By Region - Global Inflammatory Bowel Disease Relief Revenue & Forecasts
  6.2.1 By Region - Global Inflammatory Bowel Disease Relief Revenue, 2017-2022
  6.2.2 By Region - Global Inflammatory Bowel Disease Relief Revenue, 2023-2028
  6.2.3 By Region - Global Inflammatory Bowel Disease Relief Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Inflammatory Bowel Disease Relief Revenue, 2017-2028
  6.3.2 US Inflammatory Bowel Disease Relief Market Size, 2017-2028
  6.3.3 Canada Inflammatory Bowel Disease Relief Market Size, 2017-2028
  6.3.4 Mexico Inflammatory Bowel Disease Relief Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Inflammatory Bowel Disease Relief Revenue, 2017-2028
  6.4.2 Germany Inflammatory Bowel Disease Relief Market Size, 2017-2028
  6.4.3 France Inflammatory Bowel Disease Relief Market Size, 2017-2028
  6.4.4 U.K. Inflammatory Bowel Disease Relief Market Size, 2017-2028
  6.4.5 Italy Inflammatory Bowel Disease Relief Market Size, 2017-2028
  6.4.6 Russia Inflammatory Bowel Disease Relief Market Size, 2017-2028
  6.4.7 Nordic Countries Inflammatory Bowel Disease Relief Market Size, 2017-2028
  6.4.8 Benelux Inflammatory Bowel Disease Relief Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Inflammatory Bowel Disease Relief Revenue, 2017-2028
  6.5.2 China Inflammatory Bowel Disease Relief Market Size, 2017-2028
  6.5.3 Japan Inflammatory Bowel Disease Relief Market Size, 2017-2028
  6.5.4 South Korea Inflammatory Bowel Disease Relief Market Size, 2017-2028
  6.5.5 Southeast Asia Inflammatory Bowel Disease Relief Market Size, 2017-2028
  6.5.6 India Inflammatory Bowel Disease Relief Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Inflammatory Bowel Disease Relief Revenue, 2017-2028
  6.6.2 Brazil Inflammatory Bowel Disease Relief Market Size, 2017-2028
  6.6.3 Argentina Inflammatory Bowel Disease Relief Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Inflammatory Bowel Disease Relief Revenue, 2017-2028
  6.7.2 Turkey Inflammatory Bowel Disease Relief Market Size, 2017-2028
  6.7.3 Israel Inflammatory Bowel Disease Relief Market Size, 2017-2028
  6.7.4 Saudi Arabia Inflammatory Bowel Disease Relief Market Size, 2017-2028
  6.7.5 UAE Inflammatory Bowel Disease Relief Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer,Inc.
  7.1.1 Pfizer,Inc. Corporate Summary
  7.1.2 Pfizer,Inc. Business Overview
  7.1.3 Pfizer,Inc. Inflammatory Bowel Disease Relief Major Product Offerings
  7.1.4 Pfizer,Inc. Inflammatory Bowel Disease Relief Revenue in Global Market (2017-2022)
  7.1.5 Pfizer,Inc. Key News
7.2 Janssen Biotech,Inc.(Johnson&Johnson)
  7.2.1 Janssen Biotech,Inc.(Johnson&Johnson) Corporate Summary
  7.2.2 Janssen Biotech,Inc.(Johnson&Johnson) Business Overview
  7.2.3 Janssen Biotech,Inc.(Johnson&Johnson) Inflammatory Bowel Disease Relief Major Product Offerings
  7.2.4 Janssen Biotech,Inc.(Johnson&Johnson) Inflammatory Bowel Disease Relief Revenue in Global Market (2017-2022)
  7.2.5 Janssen Biotech,Inc.(Johnson&Johnson) Key News
7.3 Valeant Pharmaceuticals
  7.3.1 Valeant Pharmaceuticals Corporate Summary
  7.3.2 Valeant Pharmaceuticals Business Overview
  7.3.3 Valeant Pharmaceuticals Inflammatory Bowel Disease Relief Major Product Offerings
  7.3.4 Valeant Pharmaceuticals Inflammatory Bowel Disease Relief Revenue in Global Market (2017-2022)
  7.3.5 Valeant Pharmaceuticals Key News
7.4 Allerganplc.
  7.4.1 Allerganplc. Corporate Summary
  7.4.2 Allerganplc. Business Overview
  7.4.3 Allerganplc. Inflammatory Bowel Disease Relief Major Product Offerings
  7.4.4 Allerganplc. Inflammatory Bowel Disease Relief Revenue in Global Market (2017-2022)
  7.4.5 Allerganplc. Key News
7.5 Takeda Pharmaceutical
  7.5.1 Takeda Pharmaceutical Corporate Summary
  7.5.2 Takeda Pharmaceutical Business Overview
  7.5.3 Takeda Pharmaceutical Inflammatory Bowel Disease Relief Major Product Offerings
  7.5.4 Takeda Pharmaceutical Inflammatory Bowel Disease Relief Revenue in Global Market (2017-2022)
  7.5.5 Takeda Pharmaceutical Key News
7.6 AbbVie,Inc.
  7.6.1 AbbVie,Inc. Corporate Summary
  7.6.2 AbbVie,Inc. Business Overview
  7.6.3 AbbVie,Inc. Inflammatory Bowel Disease Relief Major Product Offerings
  7.6.4 AbbVie,Inc. Inflammatory Bowel Disease Relief Revenue in Global Market (2017-2022)
  7.6.5 AbbVie,Inc. Key News
7.7 Novartis AG
  7.7.1 Novartis AG Corporate Summary
  7.7.2 Novartis AG Business Overview
  7.7.3 Novartis AG Inflammatory Bowel Disease Relief Major Product Offerings
  7.7.4 Novartis AG Inflammatory Bowel Disease Relief Revenue in Global Market (2017-2022)
  7.7.5 Novartis AG Key News
7.8 UCB Inc.
  7.8.1 UCB Inc. Corporate Summary
  7.8.2 UCB Inc. Business Overview
  7.8.3 UCB Inc. Inflammatory Bowel Disease Relief Major Product Offerings
  7.8.4 UCB Inc. Inflammatory Bowel Disease Relief Revenue in Global Market (2017-2022)
  7.8.5 UCB Inc. Key News
7.9 Biogen Inc.
  7.9.1 Biogen Inc. Corporate Summary
  7.9.2 Biogen Inc. Business Overview
  7.9.3 Biogen Inc. Inflammatory Bowel Disease Relief Major Product Offerings
  7.9.4 Biogen Inc. Inflammatory Bowel Disease Relief Revenue in Global Market (2017-2022)
  7.9.5 Biogen Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Inflammatory Bowel Disease Relief Market Opportunities & Trends in Global Market
Table 2. Inflammatory Bowel Disease Relief Market Drivers in Global Market
Table 3. Inflammatory Bowel Disease Relief Market Restraints in Global Market
Table 4. Key Players of Inflammatory Bowel Disease Relief in Global Market
Table 5. Top Inflammatory Bowel Disease Relief Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Inflammatory Bowel Disease Relief Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Inflammatory Bowel Disease Relief Revenue Share by Companies, 2017-2022
Table 8. Global Companies Inflammatory Bowel Disease Relief Product Type
Table 9. List of Global Tier 1 Inflammatory Bowel Disease Relief Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inflammatory Bowel Disease Relief Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Inflammatory Bowel Disease Relief Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Inflammatory Bowel Disease Relief Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Inflammatory Bowel Disease Relief Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Inflammatory Bowel Disease Relief Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Inflammatory Bowel Disease Relief Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Inflammatory Bowel Disease Relief Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer,Inc. Corporate Summary
Table 31. Pfizer,Inc. Inflammatory Bowel Disease Relief Product Offerings
Table 32. Pfizer,Inc. Inflammatory Bowel Disease Relief Revenue (US$, Mn), (2017-2022)
Table 33. Janssen Biotech,Inc.(Johnson&Johnson) Corporate Summary
Table 34. Janssen Biotech,Inc.(Johnson&Johnson) Inflammatory Bowel Disease Relief Product Offerings
Table 35. Janssen Biotech,Inc.(Johnson&Johnson) Inflammatory Bowel Disease Relief Revenue (US$, Mn), (2017-2022)
Table 36. Valeant Pharmaceuticals Corporate Summary
Table 37. Valeant Pharmaceuticals Inflammatory Bowel Disease Relief Product Offerings
Table 38. Valeant Pharmaceuticals Inflammatory Bowel Disease Relief Revenue (US$, Mn), (2017-2022)
Table 39. Allerganplc. Corporate Summary
Table 40. Allerganplc. Inflammatory Bowel Disease Relief Product Offerings
Table 41. Allerganplc. Inflammatory Bowel Disease Relief Revenue (US$, Mn), (2017-2022)
Table 42. Takeda Pharmaceutical Corporate Summary
Table 43. Takeda Pharmaceutical Inflammatory Bowel Disease Relief Product Offerings
Table 44. Takeda Pharmaceutical Inflammatory Bowel Disease Relief Revenue (US$, Mn), (2017-2022)
Table 45. AbbVie,Inc. Corporate Summary
Table 46. AbbVie,Inc. Inflammatory Bowel Disease Relief Product Offerings
Table 47. AbbVie,Inc. Inflammatory Bowel Disease Relief Revenue (US$, Mn), (2017-2022)
Table 48. Novartis AG Corporate Summary
Table 49. Novartis AG Inflammatory Bowel Disease Relief Product Offerings
Table 50. Novartis AG Inflammatory Bowel Disease Relief Revenue (US$, Mn), (2017-2022)
Table 51. UCB Inc. Corporate Summary
Table 52. UCB Inc. Inflammatory Bowel Disease Relief Product Offerings
Table 53. UCB Inc. Inflammatory Bowel Disease Relief Revenue (US$, Mn), (2017-2022)
Table 54. Biogen Inc. Corporate Summary
Table 55. Biogen Inc. Inflammatory Bowel Disease Relief Product Offerings
Table 56. Biogen Inc. Inflammatory Bowel Disease Relief Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Inflammatory Bowel Disease Relief Segment by Type in 2021
Figure 2. Inflammatory Bowel Disease Relief Segment by Application in 2021
Figure 3. Global Inflammatory Bowel Disease Relief Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Inflammatory Bowel Disease Relief Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Inflammatory Bowel Disease Relief Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Inflammatory Bowel Disease Relief Revenue in 2021
Figure 8. By Type - Global Inflammatory Bowel Disease Relief Revenue Market Share, 2017-2028
Figure 9. By Application - Global Inflammatory Bowel Disease Relief Revenue Market Share, 2017-2028
Figure 10. By Region - Global Inflammatory Bowel Disease Relief Revenue Market Share, 2017-2028
Figure 11. By Country - North America Inflammatory Bowel Disease Relief Revenue Market Share, 2017-2028
Figure 12. US Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Inflammatory Bowel Disease Relief Revenue Market Share, 2017-2028
Figure 16. Germany Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 17. France Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Inflammatory Bowel Disease Relief Revenue Market Share, 2017-2028
Figure 24. China Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 28. India Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Inflammatory Bowel Disease Relief Revenue Market Share, 2017-2028
Figure 30. Brazil Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Inflammatory Bowel Disease Relief Revenue Market Share, 2017-2028
Figure 33. Turkey Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Inflammatory Bowel Disease Relief Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer,Inc. Inflammatory Bowel Disease Relief Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Janssen Biotech,Inc.(Johnson&Johnson) Inflammatory Bowel Disease Relief Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Valeant Pharmaceuticals Inflammatory Bowel Disease Relief Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Allerganplc. Inflammatory Bowel Disease Relief Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Takeda Pharmaceutical Inflammatory Bowel Disease Relief Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AbbVie,Inc. Inflammatory Bowel Disease Relief Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis AG Inflammatory Bowel Disease Relief Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. UCB Inc. Inflammatory Bowel Disease Relief Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Biogen Inc. Inflammatory Bowel Disease Relief Revenue Year Over Year Growth (US$, Mn) & (2017-2022)